First Header Logo Second Header Logo

Connection

Debra Diz to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Debra Diz has written about Drug Evaluation, Preclinical.
Debra Diz
Connection Strength
0.020
Drug Evaluation, Preclinical
  1. Robbins ME, Payne V, Tommasi E, Diz DI, Hsu FC, Brown WR, Wheeler KT, Olson J, Zhao W. The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment. Int J Radiat Oncol Biol Phys. 2009 Feb 01; 73(2):499-505.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.